NO20023640L - Fremgangsmåte for opprettholdelse av eller forbedring av syntese av muciner - Google Patents

Fremgangsmåte for opprettholdelse av eller forbedring av syntese av muciner

Info

Publication number: NO20023640L
Authority: NO; Norway
Prior art keywords: mucins; synthesis; maintaining; improving; disease states
Prior art date: 2000-02-04

Application number

NO20023640A

Other languages

English (en)

Norwegian (no)

Other versions

NO20023640D0 (no

Inventor

Olivier Ballevre

Paul-Andre Finot

Denis Breuille

Original Assignee

Nestle Sa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-02-04

Filing date

2002-07-31

Publication date

2002-09-19

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27052980&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20023640(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2001-01-30 Priority claimed from US09/774,814 external-priority patent/US6833350B2/en

2002-07-31 Application filed by Nestle Sa filed Critical Nestle Sa

2002-07-31 Publication of NO20023640D0 publication Critical patent/NO20023640D0/no

2002-09-19 Publication of NO20023640L publication Critical patent/NO20023640L/no

Links

102000015728 Mucins Human genes 0.000 title abstract 3
108010063954 Mucins Proteins 0.000 title abstract 3
238000000034 method Methods 0.000 title abstract 3
230000015572 biosynthetic process Effects 0.000 title abstract 2
229940051875 mucins Drugs 0.000 title abstract 2
238000003786 synthesis reaction Methods 0.000 title abstract 2
201000010099 disease Diseases 0.000 abstract 2
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 2
208000035143 Bacterial infection Diseases 0.000 abstract 1
AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 abstract 1
239000004473 Threonine Substances 0.000 abstract 1
230000004075 alteration Effects 0.000 abstract 1
208000022362 bacterial infectious disease Diseases 0.000 abstract 1
230000002757 inflammatory effect Effects 0.000 abstract 1
230000000968 intestinal effect Effects 0.000 abstract 1
235000016709 nutrition Nutrition 0.000 abstract 1
239000013589 supplement Substances 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
- A23L33/12—Fatty acids or derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Chemical Kinetics & Catalysis (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Nutrition Science (AREA)
General Health & Medical Sciences (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Mycology (AREA)
Hematology (AREA)
Oil, Petroleum & Natural Gas (AREA)
Obesity (AREA)
Food Science & Technology (AREA)
Polymers & Plastics (AREA)
Diabetes (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Peptides Or Proteins (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Coloring Foods And Improving Nutritive Qualities (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)

NO20023640A 2000-02-04 2002-07-31 Fremgangsmåte for opprettholdelse av eller forbedring av syntese av muciner NO20023640L (no)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US49890500A	2000-02-04	2000-02-04
US09/774,814 US6833350B2 (en)	2000-02-04	2001-01-30	Method for maintaining or improving the synthesis of mucins
PCT/EP2001/001013 WO2001056405A2 (en)	2000-02-04	2001-01-31	A method for maintaining or improving the synthesis of mucins

Publications (2)

Publication Number	Publication Date
NO20023640D0 NO20023640D0 (no)	2002-07-31
NO20023640L true NO20023640L (no)	2002-09-19

Family

ID=27052980

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20023640A NO20023640L (no)	2000-02-04	2002-07-31	Fremgangsmåte for opprettholdelse av eller forbedring av syntese av muciner

Country Status (22)

Country	Link
EP (1)	EP1255452B2 (pl)
JP (1)	JP2003533436A (pl)
CN (1)	CN1434681B (pl)
AT (1)	ATE323422T1 (pl)
AU (1)	AU784137B2 (pl)
BG (1)	BG106967A (pl)
BR (1)	BRPI0108096B1 (pl)
CA (1)	CA2399063C (pl)
CZ (1)	CZ20022978A3 (pl)
DE (1)	DE60118888T3 (pl)
DZ (1)	DZ3298A1 (pl)
ES (1)	ES2261383T5 (pl)
HR (1)	HRP20020647A2 (pl)
HU (1)	HUP0204439A3 (pl)
IL (1)	IL150977A (pl)
MA (1)	MA25656A1 (pl)
MX (1)	MXPA02007491A (pl)
NO (1)	NO20023640L (pl)
NZ (1)	NZ520605A (pl)
PL (1)	PL357078A1 (pl)
SK (1)	SK11212002A3 (pl)
WO (1)	WO2001056405A2 (pl)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP2382874A1 (en)	2003-06-23	2011-11-02	Nestec S.A.	Amino acid supplementation for a healthy microbiota ecosystem
JPWO2007004613A1 (ja) *	2005-07-01	2009-01-29	味の素株式会社	炎症性腸疾患治療薬及びＴＮＦ−α産生抑制剤
EP1971230A2 (en) *	2006-01-09	2008-09-24	Nestec S.A.	Treatment of stressed patients
WO2012133198A1 (ja) *	2011-03-25	2012-10-04	イーエヌ大塚製薬株式会社	炎症性疾患用栄養組成物
PH12014500185A1 (en)	2011-07-22	2019-10-11	Abbott Lab	Galactooligosaccharides for preventing injury and/or promoting healing of the gastrointestinal tract
EP3167895A1 (en) *	2015-11-10	2017-05-17	University College Dublin	A dietary supplement comprising beta-glucan and casein hydrolysate for improving health and growth performance in a mammal

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2459620B1 (fr) *	1979-06-26	1983-08-05	Agronomique Inst Nat Rech	Hydrolisat enzymatique total de proteines de lactoserum, obtention et application
US5162373A (en) *	1986-01-17	1992-11-10	Board Of Regents, The University Of Texas System	Methods and improved formulations for the determination and treatment of malignant disease in patients
JP2631470B2 (ja) *	1987-05-15	1997-07-16	雪印乳業株式会社	感染防御剤
CA1338682C (en) *	1988-12-23	1996-10-29	Gustavo Bounous	Biologically active undenatured whey protein concentrate as food supplement
JP2805490B2 (ja) *	1989-02-07	1998-09-30	雪印乳業株式会社	細菌毒素中和剤
JP3007694B2 (ja) *	1990-12-14	2000-02-07	雪印乳業株式会社	胃潰瘍予防または治療のための医薬及び飲食品
DE69331528T2 (de) *	1992-12-23	2002-10-31	Abbott Laboratories, Abbott Park	Medizinische nahrungsmittel für die ernährungsergänzung bei metabolischen erkrankungen von säuglingen/kleinkindern
NZ248605A (en) *	1993-05-28	1994-12-22	Abbott Lab	Enteral nutritional product comprising protein and fat
FR2711529B1 (fr) *	1993-10-28	1996-07-05	Clintec Nutrition Cy	Composition à base d'acides aminés destinée au traitement d'une infection ou d'une agression engendrant une réaction inflammatoire, chez les animaux et chez l'homme.
JPH07267855A (ja) *	1994-03-30	1995-10-17	Taiho Yakuhin Kogyo Kk	グルタミン産生剤
US5952314A (en) *	1994-04-01	1999-09-14	Demichele; Stephen Joseph	Nutritional product for a person having ulcerative colitis
US5728678A (en) *	1995-06-06	1998-03-17	Nestec Ltd.	Method and composition for providing nutrition to a renal failure patient
US5670157A (en) *	1995-12-11	1997-09-23	Nestec Ltd.	Method for reducing and controlling immunoglobulin concentrations
US5922766A (en) *	1997-07-02	1999-07-13	Acosta; Phyllis J. B.	Palatable elemental medical food
WO1999013738A1 (en) *	1997-09-16	1999-03-25	Societe Des Produits Nestle S.A.	Organ specific nutrition
CA2331921A1 (en) *	1998-06-24	1999-12-29	Boyce Thompson Institute For Plant Research, Inc.	A novel invertebrate intestinal mucin cdna and related products and methods
EP1034704A1 (en) *	1999-03-12	2000-09-13	Societe Des Produits Nestle S.A.	Nutritional composition intended for specific gastro-intestinal maturation in premature mammals
CA2387907A1 (en) *	1999-10-22	2001-05-03	The Board Of Regents Of The University Of Nebraska	Serum amyloid a isoform from colostrum

2001
- 2001-01-31 HU HU0204439A patent/HUP0204439A3/hu unknown
- 2001-01-31 AT AT01911559T patent/ATE323422T1/de not_active IP Right Cessation
- 2001-01-31 DE DE60118888T patent/DE60118888T3/de not_active Expired - Lifetime
- 2001-01-31 CA CA2399063A patent/CA2399063C/en not_active Expired - Lifetime
- 2001-01-31 AU AU40564/01A patent/AU784137B2/en not_active Ceased
- 2001-01-31 DZ DZ013298A patent/DZ3298A1/fr active
- 2001-01-31 MX MXPA02007491A patent/MXPA02007491A/es unknown
- 2001-01-31 NZ NZ520605A patent/NZ520605A/en unknown
- 2001-01-31 BR BRPI0108096A patent/BRPI0108096B1/pt active IP Right Grant
- 2001-01-31 HR HRP20020647 patent/HRP20020647A2/hr not_active Application Discontinuation
- 2001-01-31 WO PCT/EP2001/001013 patent/WO2001056405A2/en not_active Ceased
- 2001-01-31 EP EP01911559A patent/EP1255452B2/en not_active Expired - Lifetime
- 2001-01-31 JP JP2001556111A patent/JP2003533436A/ja active Pending
- 2001-01-31 PL PL01357078A patent/PL357078A1/pl not_active Application Discontinuation
- 2001-01-31 CN CN018074375A patent/CN1434681B/zh not_active Expired - Lifetime
- 2001-01-31 ES ES01911559T patent/ES2261383T5/es not_active Expired - Lifetime
- 2001-01-31 SK SK1121-2002A patent/SK11212002A3/sk unknown
- 2001-01-31 CZ CZ20022978A patent/CZ20022978A3/cs unknown
- 2001-01-31 IL IL15097701A patent/IL150977A/xx not_active IP Right Cessation
2002
- 2002-07-31 NO NO20023640A patent/NO20023640L/no unknown
- 2002-07-31 BG BG106967A patent/BG106967A/bg unknown
- 2002-08-30 MA MA26798A patent/MA25656A1/fr unknown

Also Published As

Publication number	Publication date
JP2003533436A (ja)	2003-11-11
CA2399063A1 (en)	2001-08-09
ES2261383T3 (es)	2010-06-14
PL357078A1 (pl)	2004-07-12
BG106967A (bg)	2003-04-30
DE60118888T3 (de)	2010-09-23
HUP0204439A2 (hu)	2003-04-28
AU4056401A (en)	2001-08-14
CN1434681A (zh)	2003-08-06
BRPI0108096B1 (pt)	2017-05-09
IL150977A (en)	2005-09-25
MA25656A1 (fr)	2002-12-31
ATE323422T1 (de)	2006-05-15
NZ520605A (en)	2004-06-25
EP1255452B1 (en)	2006-04-19
ES2261383T5 (es)	2010-06-18
CA2399063C (en)	2014-01-28
HUP0204439A3 (en)	2004-12-28
HRP20020647A2 (en)	2004-12-31
WO2001056405A3 (en)	2002-01-24
CZ20022978A3 (cs)	2003-02-12
DZ3298A1 (fr)	2001-08-09
EP1255452A2 (en)	2002-11-13
SK11212002A3 (sk)	2003-01-09
EP1255452B2 (en)	2010-03-03
MXPA02007491A (es)	2002-12-13
NO20023640D0 (no)	2002-07-31
DE60118888T2 (de)	2007-01-18
DE60118888D1 (de)	2006-05-24
IL150977A0 (en)	2003-02-12
WO2001056405A2 (en)	2001-08-09
AU784137B2 (en)	2006-02-09
BR0108096A (pt)	2002-10-29
CN1434681B (zh)	2010-12-08

Publication	Publication Date	Title
CY1110230T1 (el)	2015-01-14	Αναστολεις γυρασης και χρησεις αυτων
MY139124A (en)	2009-08-28	Gyrase inhibitors and uses thereof
NO20050099L (no)	2005-03-14	2-ureido-6-heteroaryl-3H-benzoimidazol-4-karboksylsyrederivater og relaterte forbindelser sa som gyrase- og/eller topoisomerase IV-inhibitorer for behandling av bakterielle infeksjoner
HUP0100566A2 (hu)	2001-07-30	Új eritromicinszármazékok
MXPA03011546A (es)	2004-03-19	Formulacion farmaceutica.
CY1108808T1 (el)	2014-04-09	Ενωσεις μοτιλιδης
MY141972A (en)	2010-08-16	Biaryloxymethylarenecarboxylic acids
BRPI0409609A (pt)	2006-04-18	mediadores do transporte reverso de colesterol para o tratamento da hipercolesterolemia
DE60128112D1 (de)	2007-06-06	Aminoalkoxybenzoyl-benzofurane oder benzothiophene, verfahren zu ihrer herstellung und die enthaltenden zusammensetzungen
NO20023640D0 (no)	2002-07-31	Fremgangsmåte for opprettholdelse av eller forbedring av syntese av muciner
EP1594509A4 (en)	2009-06-03	COMPOSITIONS AND METHODS FOR TREATMENT OF IRRITABLE COLON SYNDROME AND NON ULCEREUS DYSPEPSIS
YU58102A (sh)	2004-12-31	Postupak za održavanje ili poboljšanje sinteze mucina
BRPI0414139A (pt)	2006-10-31	métodos e composições para tratar infecções por herpes
WO2007057873A3 (en)	2007-11-22	Novel compositions to improve gut health and animal performance and methods of making the same
ATE335739T1 (de)	2006-09-15	Cak inhibitoren und deren verwendungen
NO20014788D0 (no)	2001-10-02	En sammensetning for senkning av konsentrasjonen av sykdomsfremkallende tarmpeptider
WO2003086271A3 (en)	2004-02-26	Azole derivatives as antifungal agents
ATE420852T1 (de)	2009-01-15	Verfahren und zusammensetzungen zur behandlung oder prävention von bakteriellen infektionen
CA2534483A1 (en)	2005-03-31	Composition and method for treating bezoar and trichobezoar
DE60104866D1 (de)	2004-09-16	Aminoalkenylbenzoyl-benzofurane oder benzothiophene, verfahren zur ihrer herstellung und sie enthaltende zubereitungen
MXPA05006296A (es)	2005-08-29	Uso de tiazolobenzoheterociclos para el tratamiento de la esclerosis multiple.
BRPI0414454A (pt)	2006-11-14	agentes antibacterianos
UY28951A1 (es)	2006-01-31	Pequenas moleculas para el tratamiento de hipercolesterolemia y enfermedades relacionadas
UY28952A1 (es)	2006-01-31	Mediadores del transporte inverso de colesterol para el tratamiento de la hipercolesterolemia
RU2003117895A (ru)	2005-02-20	Способ местного лечения неспецифических заболеваний эндобронхитов